0:00
21:14
Renal cell carcinoma has an estimated lifetime prevalence of 2.3% for men and 1.3% for women in the US. Affected patients in early stages can have >94% cancer-specific survival. Author William Y. Kim, MD, of the University of North Carolina joins JAMA Associate Editor David L. Simel, MD, MHS, to discuss the epidemiology, clinical presentation, pathophysiology, and management of renal cell carcinoma.
Related Content:
Flere episoder fra "JAMA Clinical Reviews"
Gå ikke glip af nogen episoder af “JAMA Clinical Reviews” - abonnér på podcasten med gratisapp GetPodcast.